Navigation Links
PharmaCM CT 2.0 to Help Pharma Manage Multinational Registries
Date:8/20/2013

NEW YORK, Aug. 20, 2013 /PRNewswire/ -- With the life sciences R&D industry undergoing a "major shift around modernization," Deloitte Analytics LLC is releasing PharmaCM CT 2.0, a solution that gives pharmaceutical and biotech companies one system for managing the clinical trial application process in both the United States and Europe.

PharmaCM CT 2.0 automates much of the activity involved in initiating clinical trials on the U.S. and European registries and in complying with ongoing disclosure and publishing requirements. It's an upgrade from PharmaCM CT 1.0 in that it supports the European Clinical Trial Database (EudraCT) in addition to its U.S. counterpart, ClinicalTrials.gov.

"Today's pharma and biotech companies play on a global stage, so they need solutions that do the same," said Thomas Wicks, general manager, Deloitte Analytics LLC and PharmaCM business leader. "Using a single platform to manage more of a firm's global trial activity will reduce time training staff and doing manual procedures."

According to Matthew Hudes, managing principal, Deloitte Consulting LLP and leader of Deloitte's biotechnology industry practice, products like PharmaCM CT 2.0 reflect a broader transformation underway working to modernize the R&D process.

"One of the promising trends in life sciences today is how drug and device development is adopting innovative process improvements – techniques that have greatly enhanced productivity in other industries," said Hudes. "PharmaCM CT 2.0 is an example of how pharma and biotech may be able to utilize these capabilities to substantially improve the R&D process."

Wicks said PharmaCM CT 2.0's functionality includes managing disclosure workflows, accepting data from multiple sources and tracking compliance dates. He also noted that it's updated frequently to reflect regulatory changes.

"This solution harmonizes data across various registries and can significantly reduce the manual labor and IT resources needed in conducting clinical trials from a global perspective," said Wicks. 

Please visit www.pharmacm.com for more information or to schedule a product demonstration.

About Deloitte's Life Sciences and Health Care Practice
Deloitte's life sciences and health care practice brings fresh insight to clients and industry stakeholders. Deloitte offers a distinctive menu of professional services delivered in an integrated approach that address many segments of the health plan, health provider and life sciences industries. For more information, visit www.deloitte.com/view/en_US/us/Industries/index.htm

As used in this document, "Deloitte" means Deloitte LLP and its subsidiaries. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.


'/>"/>
SOURCE Deloitte Analytics LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... REDWOOD CITY, Calif. , March 28, 2017 ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that the European Medicines Agency ... (sufentanil sublingual tablet, 30 mcg) Marketing Authorisation Application ... review of the MAA is underway. The MAA ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
(Date:3/27/2017)... , March 27, 2017 ... to better understand Bayer and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... in Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO Process Analytics ... power plant water and steam. , Chlorides and sulfates cause pitting and stress ... extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb levels has ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder ... few medical professionals in the country to sit on the 2017 National Advisory Board ... just 2 years Dr. Harper helped propel the clinic from a small start-up to ...
(Date:3/28/2017)... ... 28, 2017 , ... Prominant bariatric surgeon and well-known weight-loss ... offer the recently FDA-approved Obalon Balloon System to his patients. The Obalon is ... already comprehensive list of weight-loss services. Dr. Liu is proud to announce ...
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
Breaking Medicine News(10 mins):